Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis
- PMID: 1702929
- PMCID: PMC1886036
Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis
Abstract
The importance of immunologic mechanisms in psoriasis has been deduced from the ability of immunosuppressive therapies to ameliorate this common and chronic skin disease. Certainly the histology of psoriatic lesions suggests a dialogue between the hyperplastic keratinocytes and infiltrating T lymphocytes and macrophages. To begin dissecting the cytokine network involved in the pathophysiology of psoriasis, the location, in both epidermal and dermal compartments, of tumor necrosis factor-alpha, interleukin-8, intercellular adhesion molecule-1, and transforming growth factor-alpha at the protein and/or mRNA levels were identified. Tumor necrosis factor-alpha was selected as a potentially key regulatory cytokine, first because it induces cultured keratinocyte interleukin-8, intercellular adhesion molecule-1, and transforming growth factor-alpha production, and second because intercellular adhesion molecule-1 expression by keratinocytes in psoriatic epidermis had been identified previously. Using immunohistochemical localization, tumor necrosis factor-alpha was identified in 12 psoriatic lesions as intense and diffuse expression by dermal dendrocytes (macrophages) in the papillary dermis (without significant staining of endothelial cells, mast cells, or dermal Langerhans cells), and focally by keratinocytes and intraepidermal Langerhans cells. Functional interaction between the dermal dendrocytes and keratinocytes was suggested by the presence of interleukin-8 expression of suprabasal keratinocytes immediately above the tumor necrosis factor-alpha-positive dermal dendrocytes. Interleukin-8 mRNA and transforming growth factor-alpha mRNA were detectable in the epidermal roof of psoriatic lesions, but neither was detectable at the protein or mRNA levels in any normal skin specimens. Treatment of cultured human keratinocytes with phorbol ester (which experimentally produces psoriasiform changes on mouse skin) or tumor necrosis factor-alpha also increased interleukin-8 and transforming growth factor-alpha mRNAs. Further elucidation of the cellular and molecular basis for the genesis and evolution of psoriasis will provide the framework for a better evaluation of the cause and treatment of this skin disease.
Similar articles
-
The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.Arch Dermatol Res. 2008 Jan;300(1):37-45. doi: 10.1007/s00403-007-0809-y. Epub 2007 Oct 25. Arch Dermatol Res. 2008. PMID: 17960400
-
Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin.J Am Acad Dermatol. 1994 Apr;30(4):535-46. doi: 10.1016/s0190-9622(94)70059-1. J Am Acad Dermatol. 1994. PMID: 7512582
-
Altered expression of keratinocyte growth factor and its receptor in psoriasis.Am J Pathol. 1997 Dec;151(6):1619-28. Am J Pathol. 1997. PMID: 9403712 Free PMC article.
-
Lymphocyte trafficking in psoriasis: a new perspective emphasizing the dermal dendrocyte with active dermal recruitment mediated via endothelial cells followed by intra-epidermal T-cell activation.J Invest Dermatol. 1990 Nov;95(5 Suppl):35S-37S. doi: 10.1111/1523-1747.ep12505731. J Invest Dermatol. 1990. PMID: 16788628 Review.
-
Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia.J Invest Dermatol. 1995 Jul;105(1 Suppl):89S-94S. doi: 10.1111/1523-1747.ep12316121. J Invest Dermatol. 1995. PMID: 7616005 Review.
Cited by
-
Modulation of keratinocyte-derived interleukin-8 which is chemotactic for neutrophils and T lymphocytes.Am J Pathol. 1991 Oct;139(4):869-76. Am J Pathol. 1991. PMID: 1681733 Free PMC article.
-
Peptides and cytokines.Arch Dermatol Res. 1992;284 Suppl 1:S22-6. doi: 10.1007/BF00638236. Arch Dermatol Res. 1992. PMID: 1285652 Review.
-
Tumor necrosis factor-alpha in psoriasis and psoriatic arthritis: a clinical, genetic, and histopathologic perspective.Curr Rheumatol Rep. 2004 Aug;6(4):292-8. doi: 10.1007/s11926-004-0041-0. Curr Rheumatol Rep. 2004. PMID: 15251081 Review.
-
TNF-α downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-α antagonists to improve skin barrier.J Invest Dermatol. 2011 Jun;131(6):1272-9. doi: 10.1038/jid.2011.24. Epub 2011 Feb 24. J Invest Dermatol. 2011. PMID: 21346775 Free PMC article.
-
Immunohistochemical markers for arthritis in psoriasis.Ann Rheum Dis. 1994 Jul;53(7):450-4. doi: 10.1136/ard.53.7.450. Ann Rheum Dis. 1994. PMID: 7944617 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical